THE PROGNOSTIC VALUE OF BASELINE PSA BLOOD IN THE TREATMENT OF PROSTATE CANCER

THE PROGNOSTIC VALUE OF BASELINE PSA BLOOD IN THE TREATMENT OF PROSTATE CANCER

The role of the level of prostate specific antigen ( PSA) before initial therapy discusses widely as a prognostic factor in the treatment of prostate cancer (PC ). Despite the fact that many of the questions on the diagnostic and prognostic value of PSA unclear, and new markers of prostate dis...

Full description

Bibliographic Details
Main Authors:	A. A. Gritskevich, V. L. Medvedev, S. V. Mishugin, N. A. Apolskaya, I. G. Rusakov
Format:	Article
Language:	English
Published:	Bashkir State Medical University 2017-02-01
Series:	Креативная хирургия и онкология
Subjects:	prostate-specific antigen gleason score prostate cancer
Online Access:	https://www.surgonco.ru/jour/article/view/169

Similar Items

PSA DENSITY - A MARKER FOR POORLY-DIFFERENTIATED PROSTATE CANCER
by: Tosho Ganev
Published: (2025-02-01)

The role of prostate-specific antigen in the prediction of hormone-sensitive prostate cancer
by: A. A. Gritskevich, et al.
Published: (2015-12-01)

Evaluation of the pathologic results of prostate biopsies in terms of age, Gleason score and PSA level: Our experience and review of the literature
by: Selcuk Sarıkaya, et al.
Published: (2014-12-01)

AGE, TOTAL PSA, PSA DENSITY AND GLEASON SCORE, TAUS AS PREDICTIVE FACTORS IN PATIENTS WITH PROSTATE CANCER
by: Daruqutni Albar, et al.
Published: (2016-03-01)

Association between gleason score, psa level, PSAD and prostate volume, in a series of patients with prostate adenocarcinoma
by: Benedetti-Padrón Inés, et al.
Published: (2012-06-01)

Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens
by: Nelson Gianni de Lima, et al.
Published: (2013-06-01)

Association of BMI and Age with Gleason Score and PSA in Patients with Prostate Cancer
by: SA Mazloumi, et al.
Published: (2023-03-01)

Prognostic Significance of the New Prostatic Carcinoma Grade Grouping System vis-àvis Biochemical Recurrence: Experience from a Tertiary Care Centre in Dakshina Kannada District, Karnataka, India
by: Anuradha Calicut Kini Rao, et al.
Published: (2021-07-01)

Correlation and diagnostic performance of the prostate-specific antigen level with the diagnosis, aggressiveness, and bone metastasis of prostate cancer in clinical practice
by: Bannakij Lojanapiwat
Published: (2014-09-01)

The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy
by: Antonio B. Porcaro, et al.
Published: (2016-03-01)

PATTERN OF PROSTATE SPECIFIC ANTIGEN AND GLEASON SCORE IN RELATION TO IMUNOHISTOCHEMISTRY FEATURES IN PROSTATE ADENOCARCINOMA PATIENTS IN DR. HASAN SADIKIN GENERAL HOSPITAL
by: Azela Glady, et al.
Published: (2016-03-01)

Five-Year Profiles of Prostate Cancer Patients in A Tertiary Hospital in Indonesia
by: Ferry Safriadi, et al.
Published: (2021-06-01)

Perineural invasion, Gleason score and prostate specific antigen; is there any association?
by: Mohammad Yazdani, et al.
Published: (2019-10-01)

Do all patients with newly diagnosed prostate cancer need staging radionuclide bone scan? a retrospective study
by: Mohammed A. Al-Ghazo, et al.
Published: (2010-12-01)

Prostate Specific Antigen Level and Gleason Score in Indonesian Prostate Cancer Patients
by: Muhammad Imam Al Kautsar Herawan, et al.
Published: (2024-09-01)

Is Prostate Biopsy Recommended in Turkish Men with a Prostate-Specific Antigen Level between 2.5 and 4 ng/mL?
by: Gokhan Koc, MD, et al.
Published: (2017-01-01)

Chronic inflammation of the prostate type IV with respect to risk of prostate cancer
by: Antonio B. Porcaro, et al.
Published: (2014-09-01)

A novel screening strategy for clinically significant prostate cancer in elderly men over 75 years of age
by: Hiroaki Iwamoto, et al.
Published: (2021-01-01)

Comparison of Pathology and Prevalence of Prostate Cancer in Patients with PSA between 4-10 ng/ml
by: A Tabibi, et al.
Published: (2008-01-01)

Variations of Serum PSA Values at Different Time Points of Treatment Based on D’Amico Risk Stratification Groups- An Observational Analysis
by: Hashim Hafneeda, et al.
Published: (2020-02-01)

Bone scintigraphy in staging of newly diagnosed prostate cancer in regard of different risk groups
by: Sabina Sevcenco, et al.
Published: (2019-06-01)

Comparison of serum prostate specific antigen (PSA), soluble E-cadherin (sE-cad), and inosine monophosphate dehydrogenase-2 (IMPDH-2) as aggressive prostate cancer predictors
by: Ahmed Mohammed Umar, et al.
Published: (2024-08-01)

CUT-OFF POINT OF PSA AND PSA DENSITY IN PROSTATE CANCER SUSPECTED PATIENTS
by: Daniel Simanjuntak, et al.
Published: (2016-03-01)

Prostate chronic inflammation type IV and prostate cancer risk in patients undergoing first biopsy set: Results of a large cohort study
by: Antonio Benito Porcaro, et al.
Published: (2015-10-01)

The Impact of Prostate-Specific Antigen and Gleason Scores on Cardiovascular Death in Prostate Cancer Patients after Radiotherapy or Chemotherapy: A Population-Based Study
by: Huijuan He, et al.
Published: (2025-02-01)

Diagnostic Accuracy of Serum Prostate Specific Antigen and Gleason Score in Determining the Presence of Skeletal Metastasis in Prostate Cancer Patients: a Pakistani Perspective
by: Taimoor Nasir, et al.
Published: (2023-04-01)

Gleason score 6: Overdiagnosis and overtreatment?
by: Yaxiong Tang, et al.
Published: (2023-06-01)

Correlation between Prostate Specific Antigen and Prostate Biopsy Gleason Score
by: Ngwu PE, et al.
Published: (2019-12-01)

Standardized Uptake Value (SUVmax) in Organ Confined Prostate Cancer in 68-Ga-PSMA PET-CT Scan and its Correlation with Prostate Specific Antigen level and Gleason Score
by: Haider Ali, et al.
Published: (2023-06-01)

Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy
by: Yadong Guo, et al.
Published: (2019-07-01)

Metastatic prostate cancer in the modern era of PSA screening
by: Philip A. Fontenot Jr, et al.

Prostate Specific Antigen (PSA): The Historical Perspective
by: T. Ming Chu
Published: (2020-12-01)

Percentage of free prostate-specific antigen (PSA) is a useful method in deciding to perform prostate biopsy with higher core numbers in patients with low PSA cut-off values
by: Hasan Yilmaz, et al.
Published: (2015-06-01)

Prostate cancer volume associates with preoperative plasma levels of testosterone that independently predicts high grade tumours which show low densities (quotient testosterone/tumour volume)
by: Antonio B. Porcaro, et al.
Published: (2016-01-01)

The accuracy of pathological data for the prediction of insignificant prostate cancer
by: Betina Katz, et al.
Published: (2012-12-01)

Tissue Zinc Concentration in Prostate Cancer: Relationship with Prostate Specific Antigen and Gleason Score in a Cohort of Nigerian Men
by: Martin Igbokwe, et al.
Published: (2021-06-01)

Prognostic Implications of Modified Gleason Score and Gleason Grade Group in Histopathologic Study of Prostatic Adenocarcinoma: A Cross-sectional Study
by: Netra Prakash Kori, et al.
Published: (2024-11-01)

Comparison between PSA density, free PSA percentage and PSA density in the transition zone in the detection of prostate cancer in patients with serum PSA between 4 and 10 ng/ml
by: Emerson P. Gregorio, et al.
Published: (2007-04-01)

Incidence of histological prostatitis and its correlation with PSA density
by: Affonso Celso Piovesan, et al.
Published: (2009-11-01)

THE INCIDENCE AND CORRELATION OF CHRONIC PROSTATITIS WITH PSA IN BPH PATIENT
by: Daniel Mahendra Krisna, et al.
Published: (2018-07-01)